世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ジェネリック医薬品市場世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測


Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

世界のジェネリック医薬品市場規模は、2022年に3,436億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.83%の成長率(CAGR)を示し、2028年までに4605億米ドルに達すると予測しています。 ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス
2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
116 英語

 

サマリー

世界のジェネリック医薬品市場規模は、2022年に3,436億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.83%の成長率(CAGR)を示し、2028年までに4605億米ドルに達すると予測しています。

ジェネリック医薬品は、先発医薬品と生物学的に同等であり、同じ有効成分で同等の治療効果があります。また、用量、危険性、結果、副作用、強度、使用目的、投与経路も同様である。これらの医薬品は、製造に大規模な研究を必要としないため、先発医薬品よりも比較的安価です。さらに、ジェネリック医薬品の製造には、薬の有効性と安全性を測定するための臨床試験や動物実験を繰り返す必要がありません。その結果、ジェネリック医薬品は世界中で絶大な支持を集めています。

ジェネリック医薬品の市場動向:

高齢者人口の増加や、がん、糖尿病、心血管疾患などの慢性疾患の増加が、市場にプラスの影響を与える主な要因の一つとなっています。また、食生活の変化や多忙なスケジュールが様々な症状を引き起こし、それがジェネリック医薬品の世界的な需要を喚起しています。また、医療費削減やジェネリック医薬品の製造・普及を促進するための各国政府の取り組みが活発化していることも、市場の成長に寄与しています。また、効果的なジェネリック医薬品を導入し、簡単に入手できるようにすることが、主要企業の後押しとなっています。これとは別に、ジェネリック医薬品の製造コストが低いことも、市場に明るい展望をもたらしています。さらに、製薬会社や医療機関の世界的な拡大が、市場の成長をさらに後押ししています。さらに、大手メーカーが新製品を発売するためのパートナーシップ戦略に注力するようになったことが、市場の成長を後押ししています。さらに、大規模な研究開発(R&D)活動への投資の増加や医薬品の処方における技術の進歩が、市場を牽引すると予想されます。

主要な市場セグメント:

IMARC Groupは、世界のジェネリック医薬品市場レポートの各サブセグメントにおける主要トレンドの分析と、2023年から2028年までの世界および国レベルでの予測を提供しています。当レポートでは、市場を治療領域、ドラッグデリバリー、流通チャネルに基づき分類しています。

治療領域別の内訳:

中枢神経系
心血管系
皮膚科学
泌尿器・ホルモン
呼吸器
リウマチ科
糖尿病
オンコロジー
その他

中枢神経系(CNS)は、世界中で脳や脊髄の病気が増加していることから、主要な治療分野となっています。

ドラッグデリバリーによるブレークアップ:

オーラル
インジェクタブル
経皮・外用
吸入器

経口薬は、その便利な投与方法から、最も好まれる薬物送達形態であり、最小限の医療支援を必要とするものです。

流通チャネル別構成比:

小売薬局
病院内薬局

現在、ジェネリック医薬品の多くは一般用医薬品であり、処方箋を必要としないことから、小売薬局の店舗で流通しています。

国別構成比:

ユーエスエー
中国
ブラジル
ドイツ
フランス
インド
イギリス
日本
カナダ
イタリア
その他

米国は、ジェネリック医薬品の製造とアクセスを改善するために、政府当局が実施した多くの取り組みにより、市場で明確な優位性を示しています。

競合の状況:

市場は大小さまざまなメーカーが存在するため、その性質上、断片化されている。市場で活動している主要なプレーヤーには、Teva Pharmaceuticals Industries Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Fresenius SE & Co., Lupin Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, and Aspen Pharmacare Holdings Limitedなどがあります。

本レポートで回答した主な質問

1.2022年のジェネリック医薬品の世界市場規模は?
2.2023年~2028年のジェネリック医薬品の世界市場の予想成長率は?
3.世界のジェネリック医薬品市場を牽引する主要因は何か?
4.COVID-19が世界のジェネリック医薬品市場に与えた影響とは?
5.ジェネリック医薬品の世界市場における治療分野別の内訳は?
6.ジェネリック医薬品の世界市場において、ドラッグデリバリーに基づく内訳は?
7.ジェネリック医薬品の世界市場の流通チャネル別の内訳はどうなっていますか?
8.世界のジェネリック医薬品市場の主要地域は?
9.世界のジェネリック医薬品市場における主要プレイヤー/企業は?

ページTOPに戻る


目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drugs Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Country
5.5 Market Breakup by Therapy Area
5.6 Market Breakup by Drug Delivery
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter’s Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Regulations in the Generic Industry
5.13 Key Market Drivers and Success Factors
6 Performance of Key Countries
6.1 United States
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 China
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Brazil
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Germany
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 France
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 India
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 United Kingdom
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Japan
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Canada
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Italy
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Others
6.11.1 Market Trends
6.11.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Competitive Landscape
10.1 Market Structure
10.2 Market Breakup by Key Players
10.3 Key Player Profiles
10.3.1 Teva Pharmaceuticals Industries Ltd.
10.3.2 Mylan N.V.
10.3.3 Novartis AG
10.3.4 Pfizer Inc.
10.3.5 Sun Pharmaceutical Industries Ltd.
10.3.6 Fresenius SE & Co.
10.3.7 Lupin Limited
10.3.8 Endo Pharmaceuticals Inc.
10.3.9 Aurobindo Pharma Limited
10.3.10 Aspen Pharmacare Holdings Limited
11 Generic Drugs Manufacturing Process
11.1 Product Overview
11.2 Detailed Process Flow (Tablets)
11.3 Detailed Process Flow (Injectable)
11.4 Various Types of Unit Operations Involved
11.5 Mass Balance and Raw Material Requirements
12 Project Details, Requirements and Costs Involved
12.1 Land Requirements and Expenditures
12.2 Construction Requirements and Expenditures
12.3 Plant Machinery
12.4 Machinery Pictures
12.5 Raw Material Requirements and Expenditures
12.6 Packaging Requirements and Expenditures
12.7 Transportation Requirements and Expenditures
12.8 Utility Requirements and Expenditures
12.9 Manpower Requirements and Expenditures
12.10 Other Capital Investments
13 Loans and Financial Assistance
14 Project Economics
14.1 Capital Cost of the Project
14.2 Techno-Economic Parameters
14.3 Product Pricing and Margins Across Various Levels of the Supply Chain
14.4 Taxation and Depreciation
14.5 Income Projections
14.6 Expenditure Projections
14.7 Financial Analysis
14.8 Profit Analysis

List of Figure

Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Generic Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Generic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2022
Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2022
Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2022
Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Generic Drugs Industry: SWOT Analysis
Figure 9: Global: Generic Drugs Industry: Value Chain Analysis
Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis
Figure 11: USA: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 13: China: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 15: Brazil: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 17: Germany: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 19: France: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 21: India: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 25: Japan: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 27: Canada: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 29: Italy: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 31: Others: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 32: Others: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 33: Global: Generic Drugs Market: Oral (in Million US$), 2017 & 2022
Figure 34: Global: Generic Drugs Market Forecast: Oral (in Million US$), 2023-2028
Figure 35: Global: Generic Drugs Market: Injectables (in Million US$), 2017 & 2022
Figure 36: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2023-2028
Figure 37: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2017 & 2022
Figure 38: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2023-2028
Figure 39: Global: Generic Drugs Market: Inhalers (in Million US$), 2017 & 2022
Figure 40: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2023-2028
Figure 41: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2017 & 2022
Figure 42: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2023-2028
Figure 43: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2017 & 2022
Figure 44: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2023-2028
Figure 45: Global: Generic Drugs Market: Dermatology (in Million US$), 2017 & 2022
Figure 46: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2023-2028
Figure 47: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2017 & 2022
Figure 48: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2023-2028
Figure 49: Global: Generic Drugs Market: Respiratory (in Million US$), 2017 & 2022
Figure 50: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2023-2028
Figure 51: Global: Generic Drugs Market: Rheumatology (in Million US$), 2017 & 2022
Figure 52: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2023-2028
Figure 53: Global: Generic Drugs Market: Diabetes (in Million US$), 2017 & 2022
Figure 54: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2023-2028
Figure 55: Global: Generic Drugs Market: Oncology (in Million US$), 2017 & 2022
Figure 56: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2023-2028
Figure 57: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2017 & 2022
Figure 58: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2023-2028
Figure 59: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2017 & 2022
Figure 60: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2023-2028
Figure 61: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 62: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2023-2028
Figure 63: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain
Figure 64: Generic Drugs Manufacturing: Production Cost Breakup (in %)
Figure 65: Generic Drugs Manufacturing: Detailed Process Flow
Figure 66: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks
Figure 67: Generic Drugs Manufacturing: Proposed Plant Layout
Figure 68: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %)

List of Table

Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028
Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2023-2028
Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Generic Drugs Market: Competitive Structure
Table 7: Generic Drugs Market: Key Players
Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements
Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 14: Details of Financial Assistance Offered by Financial Institutions
Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$)
Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters
Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$)
Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$)
Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$)
Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)

 

ページTOPに戻る


 

Summary

The global generic drugs market size reached US$ 343.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 460.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.83% during 2023-2028.

Generic drugs are bioequivalent of branded medicines with the same active ingredients and equivalent therapeutic effects. They also have similar dosages, risks, consequences, side effects, strengths, intended use, and route of administration. They are relatively less expensive than branded drugs, as the production does not require extensive research. Besides this, the production of these drugs does not involve the repetition of clinical and animal studies to measure the effectiveness and safety of the medicine. As a result, generic drugs are gaining immense traction across the globe.

Generic Drugs Market Trends:

The growing global geriatric population and the rising occurrence of chronic medical disorders, such as cancer, diabetes, and cardiovascular diseases, represent one of the key factors positively influencing the market. In addition, changing dietary patterns and hectic schedules of individuals are leading to various conditions, which, in turn, is catalyzing the demand for generic drugs worldwide. Along with this, increasing efforts by governments of various countries to reduce healthcare costs and promote the manufacturing and uptake of generics are contributing to the market growth. They are also encouraging key players to introduce effective generic drugs and provide easy availability. Apart from this, the low production cost of generic medicines is creating a positive outlook for the market. Additionally, the expansion of the pharma companies and medical stores across the globe is further augmenting the market growth. Furthermore, the rising focus of leading manufacturers on partnership strategies to launch new products is propelling the market growth. Moreover, increasing investments in extensive research and development (R&D) activities and technological advancements in medicine formulation are anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global generic drugs market report, along with forecasts at the global and country level from 2023-2028. Our report has categorized the market based on therapy area, drug delivery, and distribution channel.

Breakup by Therapy Area:

Central Nervous System
Cardiovascular
Dermatology
Genitourinary/Hormonal
Respiratory
Rheumatology
Diabetes
Oncology
Others

The central nervous system (CNS) represents the leading therapy area due to the rising prevalence of brain and spinal cord ailments across the globe.

Breakup by Drug Delivery:

Oral
Injectables
Dermal/Topical
Inhalers

Oral medicines are the most preferred form of drug delivery due to their convenient administration, which requires minimal to no medical assistance.

Breakup by Distribution Channel:

Retail Pharmacies
Hospital Pharmacies

Presently, the majority of generic drugs are distributed through retail pharmacy stores as most generic medications are over-the-counter (OTC) medicines and require no prescription.

Breakup by Country:

United States
China
Brazil
Germany
France
India
United Kingdom
Japan
Canada
Italy
Others

The United States exhibits a clear dominance in the market on account of numerous initiatives undertaken by governing authorities to improve generic drug manufacturing and access in the country.

Competitive Landscape:

The market is fragmented in nature with the presence of various small and large manufacturers. Some of the leading players operating in the market include Teva Pharmaceuticals Industries Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Fresenius SE & Co., Lupin Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, and Aspen Pharmacare Holdings Limited.

Key Questions Answered in This Report

1. What was the size of the global generic drugs market in 2022?
2. What is the expected growth rate of the global generic drugs market during 2023-2028?
3. What are the key factors driving the global generic drugs market?
4. What has been the impact of COVID-19 on the global generic drugs market?
5. What is the breakup of the global generic drugs market based on the therapy area?
6. What is the breakup of the global generic drugs market based on the drug delivery?
7. What is the breakup of the global generic drugs market based on the distribution channel?
8. What are the key regions in the global generic drugs market?
9. Who are the key players/companies in the global generic drugs market?



ページTOPに戻る


Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drugs Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Country
5.5 Market Breakup by Therapy Area
5.6 Market Breakup by Drug Delivery
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter’s Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Regulations in the Generic Industry
5.13 Key Market Drivers and Success Factors
6 Performance of Key Countries
6.1 United States
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 China
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Brazil
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Germany
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 France
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 India
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 United Kingdom
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Japan
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Canada
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Italy
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Others
6.11.1 Market Trends
6.11.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Competitive Landscape
10.1 Market Structure
10.2 Market Breakup by Key Players
10.3 Key Player Profiles
10.3.1 Teva Pharmaceuticals Industries Ltd.
10.3.2 Mylan N.V.
10.3.3 Novartis AG
10.3.4 Pfizer Inc.
10.3.5 Sun Pharmaceutical Industries Ltd.
10.3.6 Fresenius SE & Co.
10.3.7 Lupin Limited
10.3.8 Endo Pharmaceuticals Inc.
10.3.9 Aurobindo Pharma Limited
10.3.10 Aspen Pharmacare Holdings Limited
11 Generic Drugs Manufacturing Process
11.1 Product Overview
11.2 Detailed Process Flow (Tablets)
11.3 Detailed Process Flow (Injectable)
11.4 Various Types of Unit Operations Involved
11.5 Mass Balance and Raw Material Requirements
12 Project Details, Requirements and Costs Involved
12.1 Land Requirements and Expenditures
12.2 Construction Requirements and Expenditures
12.3 Plant Machinery
12.4 Machinery Pictures
12.5 Raw Material Requirements and Expenditures
12.6 Packaging Requirements and Expenditures
12.7 Transportation Requirements and Expenditures
12.8 Utility Requirements and Expenditures
12.9 Manpower Requirements and Expenditures
12.10 Other Capital Investments
13 Loans and Financial Assistance
14 Project Economics
14.1 Capital Cost of the Project
14.2 Techno-Economic Parameters
14.3 Product Pricing and Margins Across Various Levels of the Supply Chain
14.4 Taxation and Depreciation
14.5 Income Projections
14.6 Expenditure Projections
14.7 Financial Analysis
14.8 Profit Analysis

List of Figure

Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Generic Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Generic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2022
Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2022
Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2022
Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Generic Drugs Industry: SWOT Analysis
Figure 9: Global: Generic Drugs Industry: Value Chain Analysis
Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis
Figure 11: USA: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 13: China: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 15: Brazil: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 17: Germany: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 19: France: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 21: India: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 25: Japan: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 27: Canada: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 29: Italy: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 31: Others: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 32: Others: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 33: Global: Generic Drugs Market: Oral (in Million US$), 2017 & 2022
Figure 34: Global: Generic Drugs Market Forecast: Oral (in Million US$), 2023-2028
Figure 35: Global: Generic Drugs Market: Injectables (in Million US$), 2017 & 2022
Figure 36: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2023-2028
Figure 37: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2017 & 2022
Figure 38: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2023-2028
Figure 39: Global: Generic Drugs Market: Inhalers (in Million US$), 2017 & 2022
Figure 40: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2023-2028
Figure 41: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2017 & 2022
Figure 42: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2023-2028
Figure 43: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2017 & 2022
Figure 44: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2023-2028
Figure 45: Global: Generic Drugs Market: Dermatology (in Million US$), 2017 & 2022
Figure 46: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2023-2028
Figure 47: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2017 & 2022
Figure 48: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2023-2028
Figure 49: Global: Generic Drugs Market: Respiratory (in Million US$), 2017 & 2022
Figure 50: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2023-2028
Figure 51: Global: Generic Drugs Market: Rheumatology (in Million US$), 2017 & 2022
Figure 52: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2023-2028
Figure 53: Global: Generic Drugs Market: Diabetes (in Million US$), 2017 & 2022
Figure 54: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2023-2028
Figure 55: Global: Generic Drugs Market: Oncology (in Million US$), 2017 & 2022
Figure 56: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2023-2028
Figure 57: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2017 & 2022
Figure 58: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2023-2028
Figure 59: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2017 & 2022
Figure 60: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2023-2028
Figure 61: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 62: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2023-2028
Figure 63: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain
Figure 64: Generic Drugs Manufacturing: Production Cost Breakup (in %)
Figure 65: Generic Drugs Manufacturing: Detailed Process Flow
Figure 66: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks
Figure 67: Generic Drugs Manufacturing: Proposed Plant Layout
Figure 68: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %)

List of Table

Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028
Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2023-2028
Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Generic Drugs Market: Competitive Structure
Table 7: Generic Drugs Market: Key Players
Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements
Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 14: Details of Financial Assistance Offered by Financial Institutions
Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$)
Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters
Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$)
Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$)
Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$)
Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

IMARC Services Private Limited.社の医療分野での最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る